Effects of inherited trombophilia in women with recurrent pregnancy loss
dc.contributor.author | Habibovic, Z. | |
dc.contributor.author | Zeybek, B. | |
dc.contributor.author | Sanhal, C. | |
dc.contributor.author | Eroglu, Z. | |
dc.contributor.author | Karaca, E. | |
dc.contributor.author | Ulukus, M. | |
dc.date.accessioned | 2019-10-27T21:26:50Z | |
dc.date.available | 2019-10-27T21:26:50Z | |
dc.date.issued | 2011 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Purpose of Investigation: To evaluate the prevalence and effects of inherited thrombophilia caused by factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T mutations in women with recurrent pregnancy loss. Methods: A study group of 97 women with recurrent miscarriages and a control group of 71 healthy pregnant women were included in the study. Genotype analyses for factor V Leiden, prothrombin G20210A and MTHFR C677T polymorphisms were performed by real-time polymerase chain reaction (RT-PCR). Results: The frequency of factor V Leiden, prothrombin G20210A and MTHFR C677T mutations were similar in both the study and control group. There were eight patients (8.2%) who had more than one gene mutation in the study group and one patient in the control group (1.4%). This difference was not statistically significant. Study group patients (n = 97) were compared in terms of the number of miscarriages and the abortion week, in addition to being a carrier of factor V Leiden and MTHFR C677T gene mutations. No statistically significant correlation was found between being a factor V Leiden and MTHFR C677T mutation carrier with either the number of miscarriages or the abortion week. Conclusion: Factor V Leiden, prothrombin G20210A and MTHFR C677T gene mutations are not individually related with recurrent pregnancy loss. However, combined gene mutation status may be associated with recurrent miscarriages. | en_US |
dc.identifier.endpage | 350 | en_US |
dc.identifier.issn | 0390-6663 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 22268272 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 347 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/45010 | |
dc.identifier.volume | 38 | en_US |
dc.identifier.wos | WOS:000297948600013 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | I R O G Canada, Inc | en_US |
dc.relation.ispartof | Clinical and Experimental Obstetrics & Gynecology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Recurrent pregnancy loss | en_US |
dc.subject | Factor V Leiden | en_US |
dc.subject | Prothrombin | en_US |
dc.subject | MTHFR | en_US |
dc.title | Effects of inherited trombophilia in women with recurrent pregnancy loss | en_US |
dc.type | Article | en_US |